Inventor
BRUBAKER JASON D
US36 patents
⚠️ This page may combine multiple inventors who share the name “BRUBAKER JASON D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BLUEPRINT MEDICINES CORP
16 patentsUS10584114B2Mar 10, 2020
Inhibitors of RET
BLUEPRINT MEDICINES CORP13 citations94
US10035789B2Jul 31, 2018
Compounds useful for treating disorders related to RET
BLUEPRINT MEDICINES CORP31 citations94
US10030005B2Jul 24, 2018
Inhibitors of RET
BLUEPRINT MEDICINES CORP38 citations94
US10233186B2Mar 19, 2019
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP16 citations93
US10227329B2Mar 12, 2019
Compounds useful for treating disorders related to RET
BLUEPRINT MEDICINES CORP19 citations85
US11279688B2Mar 22, 2022
Inhibitors of RET
BLUEPRINT MEDICINES CORP5 citations84
US10183928B2Jan 22, 2019
Inhibitors of RET
BLUEPRINT MEDICINES CORP13 citations84
US11534441B2Dec 27, 2022
MAP4K1 inhibitors
BLUEPRINT MEDICINES CORP3 citations72
US11718602B2Aug 8, 2023
EGFR inhibitors
BLUEPRINT MEDICINES CORP2 citations70
US11634422B2Apr 25, 2023
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP1 citations70
US11236086B2Feb 1, 2022
Substituted pyrrolopyridines as inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP1 citations62
US12042495B2Jul 23, 2024
MAP4K1 inhibitors
BLUEPRINT MEDICINES CORP1 citations61
US12595265B2Apr 7, 2026
Inhibitors of activin receptor-like kinase
BLUEPRINT MEDICINES CORP0 citations59
US12172983B2Dec 24, 2024
EGFR inhibitors
BLUEPRINT MEDICINES CORP0 citations59
US12202844B2Jan 21, 2025
MAP4K1 inhibitors
BLUEPRINT MEDICINES CORP0 citations50
US12448379B2Oct 21, 2025
Wild type kit inhibitors
BLUEPRINT MEDICINES CORP0 citations48
HARVARD COLLEGE
8 patentsUS7960559B2Jun 14, 2011
Synthesis of enone intermediate
HARVARD COLLEGE13 citations92
US7763735B2Jul 27, 2010
Synthesis of enone intermediate
HARVARD COLLEGE28 citations92
US7807842B2Oct 5, 2010
Synthesis of tetracyclines and analogues thereof
HARVARD COLLEGE25 citations91
US8907104B2Dec 9, 2014
Synthesis of enone intermediate
HARVARD COLLEGE5 citations84
US10669244B2Jun 2, 2020
Synthesis of tetracyclines and analogues thereof
HARVARD COLLEGE1 citations71
US9884830B2Feb 6, 2018
Synthesis of tetracyclines and analogues thereof
HARVARD COLLEGE2 citations71
US9365493B2Jun 14, 2016
Synthesis of tetracyclines and analogues thereof
HARVARD COLLEGE3 citations71
US11192866B2Dec 7, 2021
Synthesis of tetracyclines and analogues thereof
HARVARD COLLEGE0 citations61
MERCK SHARP & DOHME
7 patentsUS10040798B2Aug 7, 2018
Pyrrolopyridazine inhibitors of IRAK4 activity
MERCK SHARP & DOHME3 citations73
US9969749B2May 15, 2018
Inhibitors of IRAK4 activity
MERCK SHARP & DOHME6 citations71
US9943516B2Apr 17, 2018
Inhibitors of IRAK4 activity
MERCK SHARP & DOHME5 citations71
US9932350B2Apr 3, 2018
Inhibitors of IRAK4 activity
MERCK SHARP & DOHME5 citations71
US9926330B2Mar 27, 2018
Inhibitors of IRAK4 activity
MERCK SHARP & DOHME5 citations71
US10329294B2Jun 25, 2019
Pyrazolopyrimidine inhibitors of IRAK4 activity
MERCK SHARP & DOHME1 citations62
US10329295B2Jun 25, 2019
Pyrrolotriazine inhibitors of IRAK4 activity
MERCK SHARP & DOHME1 citations62
MYERS ANDREW G
4 patentsUS8580969B2Nov 12, 2013
Synthesis of enone intermediate
MYERS ANDREW G7 citations84
US8293920B2Oct 23, 2012
Synthesis of enone intermediate
MYERS ANDREW G8 citations84
US8486921B2Jul 16, 2013
Synthesis of tetracyclines and analogues thereof
MYERS ANDREW G10 citations83
US8598148B2Dec 3, 2013
Synthesis of tetracyclines and analogues thereof
MYERS ANDREW G7 citations82